Maravai Lifesciences Holdings (MRVI) executive compensation, 2026 proxy

Bernd Brust, Chief Executive Officer, was paid $10.1M in 2025. The CEO-to-median-employee pay ratio was 93:1, on median employee pay of $117,383.

Filed
April 24, 2026
Annual meeting
May 26, 2026
Pay year
2025
Named executives
7
CEO total pay
$10.1M2025
CEO to median employee
93:1median $117,383
CEO pay in equity
90%$9.1M in awards
Prior say-on-pay support
81%of votes cast
CEO Pay Ratio
93 to 1Annualized CEO pay to median employee
Median Employee Pay
$117,383Annual total compensation
Say on Pay Support
80.9%Prior year advisory vote support
CEO Stock Awards
$7,660,000Grant date fair value

How Brust was paid

$10.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary4%Stock awards76%Option awards14%Non-equity incentive4%All other compensation2%

Named executive officers

ExecutiveTotal
Bernd BrustChief Executive Officer$10,129,708
William E. Martin IIIFormer Chief Executive Officer$3,845,263
Raj AsarpotaChief Financial Officer$3,506,793
Kevin HerdeFormer Chief Financial Officer$1,730,738
Kurt OreshackSecretary and General Counsel$1,470,977
Christine DolanExecutive Vice President and General Manager, Cygnus$1,454,198
Peter Leddy, PhDChief Administrative Officer$1,849,804

What changed and why

  • $10.1MBernd Brust received total compensation of $10,129,708 for fiscal 2025 following his appointment as CEO.
  • $3.8MWilliam E. Martin III served as former CEO and received total compensation of $3,845,263.
  • $3.5MRaj Asarpota joined as Chief Financial Officer and received total compensation of $3,506,793.
  • 80.9%Say-on-pay support was 80.9% at the prior annual meeting.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.